CD274 and B-cell chronic lymphocytic leukemia: As the observation on the effect of idelalisib on PD-L1 expression could be interesting from a clinical perspective, we further studied this effect and its impact on sensitivity to eNK cells in both the B-CLL cell line Mec-1 and on cells from B-CLL patients.